Nutraceutix, Inc. Licenses Pure Encapsulations to Market Calcium D-Glucarate.

REDMOND, Wash.--(BW HealthWire)--Sept. 23, 1999--

Nutraceutix, Inc. (OTC BB:NUTX) a Redmond, Washington-based company, has licensed Pure Encapsulations the non-exclusive right to distribute health supplement products containing the patented compound Calcium D-Glucarate(TM).

Pure Encapsulations (http://www.pureencapsulations.com/), based in Sudbury, Massachusetts, is a formulator and manufacturer of over 200 proprietary nutritional supplements. The company markets exclusively to the professional channel of physicians, medical clinics, and nursing homes in the United States, and selected pharmacies in Germany, Austria, Switzerland, the United Kingdom and Sweden.

"We are proud of our new association with Nutraceutix. The science behind the development of Calcium D-Glucarate is impressive and compelling. We look forward to making this important nutrient available to the over 28,000 physicians who specify Pure Encapsulations for their patients," stated Ray Hamel, Pure Encapsulation's General Manager.

Calcium D-Glucarate is found naturally in fruits and vegetables and may enhance the body's capacity to resist many types of carcinogens and toxins. D-Glucarate is a supplement strongly endorsed by Thomas J. Slaga, Ph.D., Director of Cancer Cause and Prevention, AMC Cancer Center, Denver, Colorado, and has been shown to inhibit cancer development in laboratory animals in over 30 published cancer research journals.

Pure Encapsulations joins Vitamin Plus, Twin Lab, Nutraceutical International Corporation, Logic Tech International, Inc., Advanced Physicians Products, Country Life Vitamins, Highland Laboratories and others in adding the D-Glucarate technology to their product lines.

Nutraceutix, Inc.(RN) (http://www.nutraceutix.com/) develops, licenses and manufactures proprietary and non-proprietary private-label health supplements and related products for major health supplement companies, with distribution to health food retailers, multi-levels, and mass merchants. Nutraceutix also manufactures products for major brands utilizing proprietary processes of Controlled Delivery Technology (CDT(TM)), Molecular Dispersion Technology (MDT(TM)), and LiveBac(R) probiotic caplets, as well as health supplement products containing the patented compound Calcium D-Glucarate(TM). Nutraceutix's fermentation facility is located at corporate headquarters where it also conducts research and development for the continued development of new health supplements for humans. Nutraceutix's private-label tableting, encapsulating and packaging facility is located outside Boulder, Colorado.

Except for any historical information, the matters discussed in this press release contain forward-looking statements, including activities, events or developments that the company expects, believes or anticipates will or may occur in the future. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statement.